ClinVar Miner

Submissions for variant NM_000214.3(JAG1):c.1720G>T (p.Val574Leu)

dbSNP: rs2067320699
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Invitae RCV001035535 SCV001198864 pathogenic Alagille syndrome due to a JAG1 point mutation 2019-06-13 criteria provided, single submitter clinical testing This sequence change replaces valine with leucine at codon 574 of the JAG1 protein (p.Val574Leu). The valine residue is highly conserved and there is a small physicochemical difference between valine and leucine. This variant also falls at the last nucleotide of exon 13 of the JAG1 coding sequence, which is part of the consensus splice site for this exon. This variant is not present in population databases (ExAC no frequency). This variant was observed in an individual with a phenotype suggestive of Allagile syndrome (Invitae). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. Nucleotide substitutions within the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site, but this prediction has not been confirmed by published transcriptional studies. A different variant (c.1720G>C) giving rise to the same protein effect observed here (p.Val574Leu) has been determined to be pathogenic (PMID: 17949281). This suggests that this variant is also likely to be causative of disease. A different variant affecting this nucleotide (c.1720G>A) has been determined to be pathogenic (PMID: 27256232). Further suggesting that this nucleotide is important for normal RNA splicing, and that other variants at this position may also be pathogenic. For these reasons, this variant has been classified as Pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.